FANDOM


(clean up)
m (clean up)
Line 1: Line 1:
 
{{articletype|perry}}
 
{{articletype|perry}}
   
'''''Valifin''''' was an experimental [[Umbrella Corporation (Perry)|Umbrella]] drug undergoing clinical trials in early [[1998]]. It was designed to combat [[Wikipedia:Heart disease|heart disease]] but had a side effect of [[Wikipedia:Kidney failure|kidney failure]]. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.<ref>Perry, ''[[Resident Evil: Zero Hour|Zero Hour]]'', Chapter One.</ref>
+
'''Valifin''' was an experimental [[Umbrella Corporation (Perry)|Umbrella]] drug undergoing clinical trials in early [[1998]]. It was designed to combat [[Wikipedia:Heart disease|heart disease]] but had a side effect of [[Wikipedia:Kidney failure|kidney failure]]. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.<ref>Perry, ''[[Resident Evil: Zero Hour|Zero Hour]]'', Chapter One.</ref>
   
 
==Sources==
 
==Sources==
Line 9: Line 9:
 
[[es:Valifin]]
 
[[es:Valifin]]
 
[[Category:Umbrella Corporation]]
 
[[Category:Umbrella Corporation]]
{{stub}}
 

Revision as of 01:35, March 20, 2016

Perry universe
(Covers information from the S.D. Perry novels)

Valifin was an experimental Umbrella drug undergoing clinical trials in early 1998. It was designed to combat heart disease but had a side effect of kidney failure. This was discovered too late and Umbrella was forced to pay off the family of a girl undergoing the trial.[1]

Sources

  1. Perry, Zero Hour, Chapter One.
Community content is available under CC-BY-SA unless otherwise noted.